ARCA Cy5 EGFP mRNA (5-moUTP)
ARCA Cy5 EGFP mRNA (5-moUTP) can be used to analyze mRNA delivery and translation efficiency. The EGFP mRNA will express an enhanced version of green fluorescent protein, which was originally isolated from the jellyfish, Aequorea victoria. EGFP is a direct detection reporter gene commonly used in mammalian cell cultures to produce bright green fluorescence with an emission peak at 509 nm. EGFP mRNA labeled with cyanine 5 can be directly visualized. ARCA Cy5 EGFP mRNA (5-moUTP) is an ideal molecule for determining mRNA delivery and localization and is independent of translation.
Key features:
Fluorescent Labeling: The mRNA is covalently conjugated with Cy5 dye, enabling direct visualization of mRNA delivery, cellular uptake, and intracellular trafficking using fluorescence microscopy or flow cytometry, without the need for secondary detection steps.
ARCA Structure: ARCA is a cost-effective, co-transcriptionally added cap analog that ensures efficient translation. ARCA remains widely used in early-stage research and cost-sensitive applications due to its proven performance and favorable balance of efficiency and affordability.
Modified Nucleotides: It contains 5-methoxyuridine (5-moU) modified nucleotides, which decreases immunogenicity, enhances mRNA stability, and increases translational efficiency, resulting in more reliable and reproducible protein yield.
| mRNA Length | 996 nucleotides | ||
| Concentration | 1.0 mg/mL | ||
| Buffer | 1 mM Sodium Citrate, pH 6.4 | Storage | -40°C or below |
| General tips | Dissolve it on ice and take care to prevent RNase contamination degradation. Avoid repeated freezing and thawing as much as possible. Do not vortex. For the first time, it is gently centrifuged and divided into several parts for stand-alone use. Use RNase-free reagents and consumables, using appropriate RNase-free technology. It can not be added to the serum-containing medium until it is mixed with the transfection reagent. | ||
| Shipping Condition | ship with dry ice | ||
- 1. Nicholas W. Kreofsky, Punarbasu Roy, et al. "Blending Carbohydrate and Quinine-Based Polymers Imparts Colloidal Stability, Improved Performance, and Cell Specificity for mRNA Delivery." Biomacromolecules August 28, 2025
- 2. Yutian Ma, Rachel VanKeulen-Miller, et al. "mRNA lipid nanoparticle formulation, characterization and evaluation." Nat Protoc. 2025 Mar 11 PMID: 40069324
- 3. Cheng Ma, Michael Y T Chow, et al. "Robust peptide/RNA complexes prepared with microfluidic mixing for pulmonary delivery by nebulisation." Drug Deliv Transl Res. 2025 Jan 18 PMID: 39827227
- 4. Mingzhu Gao, Yan Li, et al. "Targeted mRNA Nanoparticles Ameliorate Blood−Brain Barrier Disruption Postischemic Stroke by Modulating Microglia Polarization." ACS Nano. 2024 Jan 30;18(4):3260-3275 PMID: 38227975
- 5. LaurenEWaggoner, KatelynFMiyasaki, et al. "Analysis of PEG-lipid anchor length on lipid nanoparticle pharmacokinetics and activity in a mouse model of traumatic brain injury." Biomater Sci. 2023 Jun 13;11(12):4238-4253 PMID: 36987922
- 6. Cheng Huang , Xing Duan, et al. "Lipid Nanoparticle Delivery System for mRNA Encoding B7H3-redirected Bispecific Antibody Displays Potent Antitumor Effects on Malignant Tumors." Adv Sci (Weinh). 2023 Jan;10(3):e2205532 PMID: 36403209
- 7. Yan Cao, Zongxing He, et al. "Helper-Polymer Based Five-Element Nanoparticles (FNPs) for Lung-Specific mRNA Delivery with Long-Term Stability after Lyophilization." Nano Lett. 2022 Aug 24;22(16):6580-6589 PMID: 35969167
- 8. Chen Q, Gao M, et al. "Biodegradable nanoparticles decorated with different carbohydrates for efficient macrophage-targeted gene therapy." J Control Release. 2020 Apr 22;323:179-190 PMID: 32334322
Quality Control & Datasheet
- View current batch:
Related Biological Data
Related Biological Data
Related Biological Data
It can be based on your experimental goals:
- For Tracking Transfection and Translation Efficiency: APExBIO Reporter Gene mRNAs (e.g. EGFP, Firefly Luciferase mRNA) are commonly used to track transfection efficiency and protein expression duration; evaluate gene expression and cell viability; study mRNA localization and bio-distribution via in vivo imaging; optimize transfection conditions and validate LNP delivery system.
- For Gene Editing, Functional Studies and Gene Therapy Research: APExBIO offers various functional protein mRNAs, involving tumor suppressors (e.g. p53, PTEN), cytokines (e.g. IL-12, IL-10), gene-editing tools (e.g. spCas9, Cre Recombinase), gene replacement protein (e.g. EPO), and antigens (e.g. OVA, SARS-CoV-2 Spike).
- For Sustained Protein Expression: APExBIO Self-amplifying RNA (saRNA) and Circular RNA (circRNA) are recommended for applications requiring prolonged protein expression. saRNA enables lasting and strong protein expression at lower doses, while circRNA has enhanced structural stability and extended expression duration.
- Advanced Capping Technology: Utilizes Cap 1 structure (EZ Cap™ Cap) to achieve enhanced translation efficiency and minimizing activation of the host innate immune response. The capping efficiency can reach 90–99%.
- Diverse Modification Options: Provides a range of modified nucleotides, such as m1Ψ B8049, 5-moUTP B8061 and Cy5-UTP B8333, which reduce immunogenicity, improve mRNA stability, and maximize protein expression levels.
- Stringent Quality Control: Each batch undergoes rigorous quality assessment including capping efficiency, purity, integrity, and sterility to ensure batch-to-batch consistency.
